Dr. Oz jumps in as drug exec collapses during Oval Office press conference

Drug Executive Collapses During Oval Office Press Conference

A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump was announcing a deal with pharmaceutical companies to lower obesity drug prices.

Incident Details

During the event on Thursday, Trump and representatives from Eli Lilly and Novo Nordisk discussed a new agreement to expand coverage and reduce costs for obesity treatments Zepbound and Wegovy.

David Ricks, CEO of Eli Lilly, was speaking when he noticed the executive collapse. He said,

“Are you okay? Gordon, are you okay?”

Response and Individuals Involved

The man who fainted was identified as Gordon Findlay, the global brand director for Novo Nordisk. Dr. Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, quickly stepped in to assist as Findlay fell to his knees and collapsed.

Health and Human Services Secretary was also present during the incident. The press was asked to leave temporarily as assistance was provided to Findlay.

Aftermath

About 30 minutes later, the press conference resumed, and President Trump provided an update on the executive’s condition.

Summary

The event highlighted a serious moment during the announcement of a significant drug pricing deal, with quick medical intervention and continued commitment to reducing obesity drug costs.

President Trump gave an update on the executive's health after the incident, underscoring the cooperation between government and drugmakers.

Author's summary: A drug executive fainted during a White House press conference on drug pricing, prompting quick aid from officials and a resumed discussion on obesity treatment affordability.

more

FOX 2 Detroit FOX 2 Detroit — 2025-11-06

More News